What This Differential Supports, and What It Doesn't

This case supports a specific, bounded set of statements: the specimen was adequate by recovered volume, pooled volume, contamination, and processing-time criteria; the differential shows concurrent lymphocytic, neutrophilic, and eosinophilic patterns by the numeric thresholds used here, with the lymphocyte shift dominant; and no finding present required escalation to cytopathology or microbiology. None of that establishes a diagnosis. A lymphocytic BAL pattern is a nonspecific, supportive finding, and the same pattern can appear with sarcoidosis, hypersensitivity pneumonitis, drug reaction, and other interstitial lung diseases; distinguishing between them depends on clinical history, imaging, and often additional testing well beyond a cytospin differential.

Several pieces are explicitly method- or policy-dependent rather than fixed numbers. The exact unit convention for reporting a total nucleated cell count (cells per microliter versus cells per milliliter) and whether an absolute subtype count is reported alongside the percentage differential are local reporting choices. The Golde score and lipid-laden macrophage index cutoffs used, if either is offered at all, are locally defined or literature-sourced, not a single consensus number. The threshold used locally to call a specimen inadequate for cellularity, such as macrophages under about 10 per high-power field, is also a local convention layered on top of the general adequacy factors described above.

Several requirements sit behind the workflow without being BAL-specific. A laboratory offering body fluid cell counts in duplicate must define limits of agreement between replicate counts and document corrective action when those limits are exceeded. The laboratory must evaluate consistency of morphologic observation among everyone performing body fluid differentials at least annually, with acceptability criteria set by the laboratory director, and must maintain a reference file or atlas of body fluid cytomorphology at the bench.

Body fluid slides are retained for at least one week for possible review, longer at local discretion for significantly abnormal smears. Personnel performing this testing are assessed for competency using the standard elements applied to any nonwaived test system. None of these requirements is written specifically for BAL; they apply at the level of body fluid analysis generally, and no CAP requirement naming bronchoalveolar lavage specifically was found.

A BAL differential earns its place as supportive evidence only when the specimen behind it has already been judged adequate, and even then it describes a pattern, not a diagnosis.